Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

World Cancer Leader's Summit /
Issues surrounding trials for rare cancers

17th - 18th Nov 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.11.15
Views: 1473
Rating:

Prof Matt Seymour - National Institute for Health Research, UK

Prof Seymour talks to ecancertv at the World Cancer Leaders Summit in Istanbul, Turkey, about his involvement in the International Rare Cancers Initiative.

He discusses the issues surrounding rare cancers and the difficulties in the implementation of clinical research projects due to the low numbers of patients.

With individual countries lacking the required cases and funds to run practice changing randomised trials Prof Seymour stresses the need for international collaboration. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation